GSK Gsk Plc

TIDMGSK

RNS Number : 3991V

GlaxoSmithKline PLC

02 December 2019

GlaxoSmithKline plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 30 November 2019 consisted of 5,382,827,454 shares of 25 pence each ('Ordinary Shares'), of which 393,505,950 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,989,321,504. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

V A Whyte

Company Secretary

2 December 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRUGGWAPUPBGQP

(END) Dow Jones Newswires

December 02, 2019 11:54 ET (16:54 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024